Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F24%3A00009904" target="_blank" >RIV/00023884:_____/24:00009904 - isvavai.cz</a>
Výsledek na webu
<a href="https://www-sciencedirect-com.ezproxy.lib.cas.cz/science/article/abs/pii/S2405500X24000112?via%3Dihub" target="_blank" >https://www-sciencedirect-com.ezproxy.lib.cas.cz/science/article/abs/pii/S2405500X24000112?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jacep.2023.12.015" target="_blank" >10.1016/j.jacep.2023.12.015</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation
Popis výsledku v původním jazyce
BACKGROUND In treating atrial fibrillation, pulsed - field ablation (PFA) has comparable ef ficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n =10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate -severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 +/- 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild -moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild -moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST -segment changes. CONCLUSIONS Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm. (J Am Coll Cardiol EP 2024;10:885 -896) (c) 2024 by the American College of Cardiology Foundation.
Název v anglickém jazyce
Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation
Popis výsledku anglicky
BACKGROUND In treating atrial fibrillation, pulsed - field ablation (PFA) has comparable ef ficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n =10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate -severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 +/- 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild -moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild -moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST -segment changes. CONCLUSIONS Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm. (J Am Coll Cardiol EP 2024;10:885 -896) (c) 2024 by the American College of Cardiology Foundation.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30201 - Cardiac and Cardiovascular systems
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
JACC: Clinical Electrophysiology
ISSN
2405-500X
e-ISSN
—
Svazek periodika
10
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
12
Strana od-do
885-896
Kód UT WoS článku
001246649500001
EID výsledku v databázi Scopus
2-s2.0-85187574086